Report copyright - Investor Presentation July 2012 - AceAnalyser Meet/132523_20120725.pdf · •Global Phase I trial for Biosimilar Insulin Glargine successfully completed. •Itolizumab Phase III,
Please pass captcha verification before submit form
Please pass captcha verification before submit form